[1]
“Development and Validation of new UPLC method for the simultaneous estimation of darunavir, dolutegravir and ritonavir in combined tablet dosage form”, AJPHS, vol. 12, no. 1, pp. 2624–2628, Mar. 2022, doi: 10.5530/nc9nr802.